New oral anticoagulants: key messages for clinicians

New oral anticoagulants: key messages for clinicians

New oral anticoagulants are an effective and safe alternative to vitamin K antagonists in many fields of clinical practice. The use of the direct inhibitors of activated Factor II (dabigatran) and activated Factor X (apixaban and rivaroxaban), both in patients with non-valvular atrial fibrillation (...

Full description

Bibliographic Details
Main Authors:	Matteo Giorgi-Pierfranceschi, Chiara Cattabiani, Francesco Dentali
Format:	Article
Language:	English
Published:	PAGEPress Publications 2013-12-01
Series:	Italian Journal of Medicine
Subjects:	new oral anticoagulants, internal medicine, management checklist.
Online Access:	http://www.italjmed.org/index.php/ijm/article/view/465

Similar Items

Beyond warfarin: The advent of new oral anticoagulants
by: Sandeep T Laroia, et al.
Published: (2015-10-01)

How to effectively reverse life-thretening effects of non-vitamin K oral anticoagulants?
by: Łukasz Wołowiec, et al.
Published: (2017-02-01)

How to effectively reverse life-thretening effects of non-vitamin K oral anticoagulants?
by: Łukasz Wołowiec, et al.
Published: (2017-02-01)

EXTENDED THERAPY OF VENOUS THROMBOSIS BY ORAL ANTICOAGULANTS: FOCUS AT SAFETY
by: I. V. SCHASTLIVTSEV, et al.
Published: (2016-12-01)

New oral anticoagulants and their reversal agents
by: Crista L. Laslo, et al.
Published: (2018-10-01)

COMPARISON OF BLEEDING RISKS WITH NEW ORAL ANTICOAGULANTS VERSUS ACENOCUMAROLUM – part 1
by: Roxana Radu, et al.
Published: (2022-03-01)

COMPARISON OF BLEEDING RISKS WITH NEW ORAL ANTICOAGULANTS VERSUS ACENOCUMAROLUM – part 2
by: Roxana Radu, et al.
Published: (2022-03-01)

Effects of the availability of new oral anticoagulants in patients with non-valvular atrial fibrillation in the real world: the NAIF study
by: Francesco Ventrella, et al.
Published: (2016-07-01)

Application of new orally anticoagulants in patients with chronic kidney disease
by: WANG Xiu-heng, WU Jie, HU Heng-jing
Published: (2020-08-01)

PHARMACOGENETIC ASPECTS OF NEW ORAL ANTICOAGULANTS APPLICATION
by: A. V. Kryukov, et al.
Published: (2017-07-01)

Monitoring strategies for patients treated with the new oral anticoagulants and the need for laboratory evaluation of hemostasis
by: Andrea Fontanella, et al.
Published: (2013-12-01)

Assessment of novel oral anticoagulant use within a community teaching hospital
by: Sultan Alghadeer, et al.
Published: (2017-01-01)

Non-vitamin K oral anticoagulant in the prevention and treatment of venous thromboembolism. Why betrixaban is different?
by: Łukasz Wołowiec, et al.
Published: (2017-08-01)

Non-vitamin K oral anticoagulant in the prevention and treatment of venous thromboembolism. Why betrixaban is different?
by: Łukasz Wołowiec, et al.
Published: (2017-08-01)

Differences in Preferences Between Clinicians and Patients for the Use and Dosing of Direct Oral Anticoagulants for Atrial Fibrillation
by: Jennifer A. Rymer, et al.
Published: (2021-06-01)

DIRECT ORAL ANTICOAGULANTS
by: I. Tzoran, et al.
Published: (2016-06-01)

State and adequacy of anticoagulant therapy in fibrillation of precurities in clinical practice
by: A. A. Tuchkov, et al.
Published: (2021-06-01)

Hepatotoxicity of New Oral Anticoagulants
by: A. R. Kasimova, et al.
Published: (2018-09-01)

THE PROBLEM OF THE USE OF NEW ORAL ANTICOAGULANTS IN CANCER PATIENTS RECEIVING CHEMOTHERAPY
by: A. A. Rumyantsev, et al.
Published: (2015-09-01)

The use of oral anticoagulants in patients with atrial fibrillation: cohort study data
by: O. V. Gaisenok, et al.
Published: (2016-09-01)

The treatment of venous thromboembolism with new oral anticoagulants
by: Davide Imberti
Published: (2013-12-01)

Ex Vivo Antiplatelet Effects of Oral Anticoagulants
by: Giulia Renda, et al.
Published: (2024-03-01)

Influence of novel oral anticoagulants on anticoagulation care management
by: Janzic Andrej, et al.
Published: (2017-09-01)

New Oral Anticoagulants Open New Horizons for Cancer Patients with Venous Thromboembolism
by: Wumaier K, et al.
Published: (2022-08-01)

Intracranial hemorrhage in patients taking oral anticoagulants. Current possibilities for therapy
by: S. N. Yanishevsky
Published: (2019-06-01)

Patient Perspectives on Factors Affecting Direct Oral Anticoagulant Use for Stroke Prevention in Atrial Fibrillation
by: Medlinskiene K, et al.
Published: (2021-05-01)

Effect of new oral anticoagulants on microcirculation in ischemic diabetic foot ulcer
by: Khaled Attia, et al.
Published: (2022-01-01)

Knowledge base and practice among clinicians regarding oral anticoagulant therapy: A questionnaire survey
by: J D David Livingston, et al.
Published: (2017-01-01)

Antidotes for the new oral anticoagulant drugs!
by: Jawed Fareed, et al.
Published: (2019-01-01)

Sepsis in internal wards: results of an Italian multicenter prospective study
by: Matteo Giorgi-Pierfranceschi, et al.
Published: (2016-12-01)

THE EFFICACY AND SAFETY OF NEW ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION IN CLINICAL PRACTICE
by: S. V. Moiseev
Published: (2016-05-01)

Clinical Use of Direct Oral Anticoagulants and Reversal: Consideration for Vascular Surgeons
by: Alan Houben, et al.
Published: (2023-06-01)

The effect of oral anticoagulant use before visit for patients with COVID-19 on mortality: A meta-analysis
by: Cornelia Ghea, et al.
Published: (2023-01-01)

How to manage new oral anticoagulants in case of surgery
by: Davide Imberti
Published: (2013-12-01)

PATTERN OF ANTICOAGULANT THERAPY IN CARDIOEMBOLIC STROKE
by: Reihan Achmad Reza, et al.
Published: (2023-06-01)

New Direct Oral Anticoagulants (DOAC) and Their Use Today
by: Heike Schwarb, et al.
Published: (2016-03-01)

Adherence to Treatment with New Oral Anticoagulants in Atrial Fibrillation Patients in Real Clinical Practice (Results of the ANTEY Study)
by: S. Yu. Martsevich, et al.
Published: (2020-01-01)

New Oral Anticoagulants May Be Particularly Useful for Asian Stroke Patients
by: Oh Young Bang, et al.
Published: (2014-05-01)

Practical Considerations for Use of Direct Oral Anticoagulants in Children
by: Hilary Whitworth, et al.
Published: (2022-04-01)

Hemorrhagic stroke and oral anticoagulants: What is to be done?
by: M. A. Domashenko
Published: (2016-03-01)